Pacira BioSciences, Inc.
US ˙ NasdaqGS ˙ US6951271005

SecurityPCRX / Pacira BioSciences, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership562,040 shares
Latest Disclosed Value $ 12,702,104
UBS Group AG ownership in PCRX / Pacira BioSciences, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 562,040 shares of Pacira BioSciences, Inc. (US:PCRX) valued at $12,702,104 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 558,651 shares of Pacira BioSciences, Inc.. This represents a change in shares of 0.61% during the quarter. The current value of the position is $12,741,447 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (PCRX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

PCRX / Pacira BioSciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F PACIRA BIOSCIENCES COM 695127100 562,040 3,389 0.61 12,702 -12.14 0.0004
2026-01-29 2025-12-31 13F PACIRA BIOSCIENCES COM 695127100 558,651 -296,210 -34.65 14,458 -34.37 0.0023
2025-11-13 2025-09-30 13F PACIRA BIOSCIENCES COM 695127100 854,861 -174,028 -16.91 22,030 -10.41 0.0035
2025-08-14 2025-06-30 13F PACIRA BIOSCIENCES COM 695127100 1,028,889 607,057 143.91 24,590 134.59 0.0043
2025-05-13 2025-03-31 13F PACIRA BIOSCIENCES COM 695127100 421,832 -952,957 -69.32 10,483 -59.53 0.0019
2025-02-14 2024-12-31 13F PACIRA BIOSCIENCES COM 695127100 1,374,789 1,184,034 620.71 25,901 802.47 0.0048
2024-11-14 2024-09-30 13F PACIRA BIOSCIENCES COM 695127100 190,755 125,097 190.53 2,871 52.82 0.0006
2024-08-14 2024-06-30 13F PACIRA BIOSCIENCES COM 695127100 65,658 -99,803 -60.32 1,878 -61.15 0.0005
2024-05-13 2024-03-31 13F PACIRA BIOSCIENCES COM 695127100 165,461 39,875 31.75 4,835 14.09 0.0012
2024-02-09 2023-12-31 13F PACIRA BIOSCIENCES COM 695127100 125,586 69,513 123.97 4,237 146.34 0.0013
2023-11-09 2023-09-30 13F PACIRA BIOSCIENCES COM 695127100 56,073 31,699 130.05 1,720 76.23 0.0006
2023-08-11 2023-06-30 13F PACIRA BIOSCIENCES COM 695127100 24,374 -5,177 -17.52 977 -19.00 0.0003
2023-05-12 2023-03-31 13F PACIRA BIOSCIENCES COM 695127100 29,551 2,145 7.83 1,206 13.89 0.0004
2023-02-08 2022-12-31 13F PACIRA BIOSCIENCES COM 695127100 27,406 6,763 32.76 1,058 -3.64 0.0004
2022-11-10 2022-09-30 13F PACIRA BIOSCIENCES COM 695127100 20,643 -1,642 -7.37 1,098 -15.47 0.0005
2022-08-10 2022-06-30 13F PACIRA BIOSCIENCES COM 695127100 22,285 764 3.55 1,299 -20.89 0.0005
2022-05-16 2022-03-31 13F PACIRA BIOSCIENCES COM 695127100 21,521 -2,027 -8.61 1,642 15.88 0.0005
2022-02-14 2021-12-31 13F PACIRA BIOSCIENCES COM 695127100 23,548 -1,533 -6.11 1,417 0.85 0.0004
2021-11-15 2021-09-30 13F PACIRA BIOSCIENCES COM 695127100 25,081 -10,422 -29.36 1,405 -34.77 0.0004
2021-08-13 2021-06-30 13F PACIRA BIOSCIENCES COM 695127100 35,503 -12,500 -26.04 2,154 -35.99 0.0007
2021-05-12 2021-03-31 13F PACIRA BIOSCIENCES COM 695127100 48,003 -13,283 -21.67 3,365 -8.24 0.0011
2021-02-11 2020-12-31 13F PACIRA BIOSCIENCES COM 695127100 61,286 36,384 146.11 3,667 144.96 0.0012
2020-11-12 2020-09-30 13F PACIRA BIOSCIENCES COM 695127100 24,902 -13,516 -35.18 1,497 -25.74 0.0006
2020-07-31 2020-06-30 13F PACIRA BIOSCIENCES COM 695127100 38,418 -8,765 -18.58 2,016 27.43 0.0009
2020-05-01 2020-03-31 13F PACIRA BIOSCIENCES COM 695127100 47,183 -27,529 -36.85 1,582 -53.26 0.0007
2020-02-14 2019-12-31 13F PACIRA BIOSCIENCES COM 695127100 74,712 56,874 318.84 3,385 398.53 0.0012
2019-11-14 2019-09-30 13F PACIRA BIOSCIENCES COM 695127100 17,838 -900 -4.80 679 -16.69 0.0003
2019-08-14 2019-06-30 13F PACIRA BIOSCIENCES COM 695127100 18,738 2,250 13.65 815 29.78 0.0003
2019-05-14 2019-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 16,488 9,264 128.24 628 101.93 0.0003
2019-02-14 2018-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 7,224 -1,149 -13.72 311 -24.33 0.0001
2018-11-14 2018-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 8,373 621 8.01 411 65.73 0.0002
2018-08-14 2018-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 7,752 -17,384 -69.16 248 -68.33 0.0001
2018-05-15 2018-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 25,136 -1,100 -4.19 783 -34.64 0.0003
2018-02-14 2017-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 26,236 2,310 9.65 1,198 33.26 0.0005
2017-11-14 2017-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 23,926 6,117 34.35 899 5.89 0.0004
2017-11-14 2017-06-30 13F/A-1 PACIRA PHARMACEUTICALS COM 695127100 17,809 3,336 23.05 849 28.64 0.0004
2017-08-14 2017-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 17,809 3,336 849
2017-11-14 2017-03-31 13F/A-1 PACIRA PHARMACEUTICALS COM 695127100 14,473 7,117 96.75 660 177.31 0.0004
2017-05-12 2017-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 14,473 7,117 660
2017-02-14 2016-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 7,356 2,392 48.19 238 40.00 0.0001
2016-11-14 2016-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 4,964 -408 -7.59 170 -6.08 0.0001
2016-08-12 2016-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 5,372 -416 -7.19 181 -41.04 0.0001
2016-05-12 2016-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 5,788 -501 -7.97 307 -36.44 0.0002
2016-02-16 2015-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 6,289 349 5.88 483 97.95 0.0003
2015-11-13 2015-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 5,940 5,096 603.79 244 313.56 0.0002
2015-08-14 2015-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 844 -12,353 -93.60 59 -94.97 0.0000
2015-05-14 2015-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 13,197 -5,970 -31.15 1,172 -31.02 0.0008
2015-02-17 2014-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 19,167 19,167 1,699 0.0012
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2015-05-14 2015-03-31 13F PACIRA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-17 2014-12-31 13F PACIRA PHARMACEUTICALS COM Call 200 18 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2018-08-14 2018-06-30 13F PACIRA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-15 2018-03-31 13F PACIRA PHARMACEUTICALS COM Put 8,700 271 n/a n/a n/a
2015-05-14 2015-03-31 13F PACIRA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-17 2014-12-31 13F PACIRA PHARMACEUTICALS COM Put 4,900 434 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.